General Hospital Psychiatry
Volume 32, Issue 5 , Pages 556-558 , September 2010

Successful treatment of comorbid obsessive–compulsive disorder with aripiprazole in three patients with bipolar disorder

Received 17 May 2010 ,Accepted 13 July 2010.

References 

  1. Kıvırcık Akdede BB, Alptekin K, Akvardar Y, Kitiş A. Quality of life in patients with obsessive–compulsive disorder: relations with cognitive functions and clinical symptoms. Turk Psikiyat Derg. 2005;16:13–19(in Turkish)
  2. Bobes J, González MP, Bascarán MT, Arango C, Sáiz PA, Bousoño M. Quality of life and disability in patients with obsessive–compulsive disorder. Eur Psychiatry. 2001;16:239–245
  3. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161:2222–2229
  4. McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420–426
  5. Tamam L, Ozpoyraz N. Comorbidity of anxiety disorder among patients with bipolar disorder in remission. Psychopathology. 2002;35:203–209
  6. Koyuncu A, Tükel R, Özyıldırım İ, Meteris H, Yazıcı O. Impact of obsessive–compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder. Compr Psychiatry. 2010;51:293–297
  7. Joshi G, Mick E, Wozniak J, Geller D, Park J, Strauss S, et al. Impact of obsessive–compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder. Bipolar Disord. 2010;12:196–204
  8. Hirose T, Uwahodo Y, Yamada S, Miwa T, Kikuchi T, Kitagawa H, et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol. 2004;18:375–383
  9. Arbaizar B, Dierssen-Sotos T, Gómez-Acebo I, Llorca J. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials. Gen Hosp Psychiatry. 2009;31:478–483
  10. McIntyre RS. Aripiprazole fort he maintenance treatment of bipolar I disorder: a review. Clin Ther. 2010;32(Suppl A):S32–S38
  11. Glick ID, Poyurovsky M, Ivanova O, Koran LM. Aripiprazole in schizophrenia patients with comorbid obsessive–compulsive symptoms. An open-label study of 15 patients. J Clin Psychiatry. 2008;69:1856–1859
  12. Pessina E, Albert U, Bogetto F, Maina G. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study. Int Clin Psychopharmacol. 2009;24:265–269
  13. Fornaro M, Gabrielli F, Vinciguerra V, Fornaro P. Aripiprazole augmentation in poor insight obsessive–compulsive disorder: a case report. Ann Gen Psychiatry. 2008;7:26
  14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, DC: American Psychiatric Press; 1997;
  15. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale–Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry. 1989;46:1006–1011
  16. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR. The use of aripiprazole in obsessive–compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry. 2005;66:49–51
  17. Raja M, Azzoni A. Clinical management of obsessive–compulsive bipolar comorbidity: a case series. Bipolar Disord. 2004;6:164–170
  18. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu L, Sibley DR, et al. Aripiprazole, a novel atypical antipsychotic drug wit a unique and robust pharmacology. Neuropsychopharmacology. 2003;28:1400–1411
  19. Skapinakis P, Papatheodorou T, et al. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol. 2007;17:79–93

PII: S0163-8343(10)00142-8

doi: 10.1016/j.genhosppsych.2010.07.004

General Hospital Psychiatry
Volume 32, Issue 5 , Pages 556-558 , September 2010

Article Tools